1.
Khorshid O, Ramadan SM. EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS. Mediterr J Hematol Infect Dis [Internet]. 2015 Oct. 16 [cited 2024 Oct. 6];7(1):e2015058. Available from: https://www.mjhid.org/mjhid/article/view/2015.058